Cargando...
A review of the efficacy and safety of eslicarbazepine acetate in the management of partial-onset seizures
Eslicarbazepine acetate is a is a once-daily antiepileptic drug (AED) that was approved in 2009 by the European Medicines Agency (EMA) (Zebinix™), and in 2013 by the US Food and Drug Administration (FDA) (Aptiom™) as adjunctive therapy in adults with refractory partial-onset seizures, with or withou...
Gardado en:
| Publicado en: | Ther Adv Neurol Disord |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
SAGE Publications
2015
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4480532/ https://ncbi.nlm.nih.gov/pubmed/26136845 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285615589711 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|